Clinical TrialID 443
High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
NCT00547547
Unspecified Adult Solid Tumor, Protocol Specific
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 443
- Evidence Id
- 443
- Core Evidence Id
- 443
- Source Clinical Trial Id
- 429
- Herb2 Clinical Trial Id
- HBCT000429
- Nct Id
- NCT00547547
- Title
- High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Unspecified Adult Solid Tumor, Protocol Specific
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DIETARY_SUPPLEMENT: high-selenium Brassica juncea|DRUG: capecitabine|DRUG: irinotecan hydrochloride
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 22
- Outcome Measure
- Maximum tolerated dose of high-selenium Brassica juncea, irinotecan hydrochloride and capecitabine, After two 21 day cycles of treatment|Toxicity, After two 21 day cycles of treatment|Pharmacokinetics, For patients treated at the MTD only at the end of cycle one of treatment
- Sponsor Collaborator
- City of Hope Medical Center|National Cancer Institute (NCI)
- Funded By
- OTHER
- Location
- City of Hope Medical Center, Duarte, California, 91010-3000, United States|South Pasadena Cancer Center, Pasadena, California, 91105, United States
- Other Id
- 05122|P30CA033572|CHNMC-05122|CDR0000570284
- Start Date
- 2006-04
- Primary Completion Date
- 2012-08
- Completion Date
- 2012-08
- First Posted
- 2007-10-22
- Results First Posted
- Last Update Posted
- 2015-11-06
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00547547
- Title Cn
- Title En
- High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer
- Bilingual Status
- semi_complete